微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 9.23% | 65.41% | 278.28% | 30/160 | 4.14% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 2.44% | 6.55% | 16.75% | 74/160 | 2.6% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 2.09% | 54.81% | -58.37% | 57/160 | 2.3% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.02% | 92.34% | -10.04% | 62/160 | -0.96% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 5.58% | 101.44% | 143.67% | 61/160 | 2.37% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 2.29% | 112.04% | 69.63% | 80/160 | 1.51% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 1.35% | -0.74% | -48.28% | 77/160 | 1.38% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 2.61% | 137.27% | -5.78% | 93/160 | 0.8% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 2.77% | 7.78% | 156.48% | 88/160 | 2.89% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 1.08% | -35.33% | -20.59% | 104/160 | 2.24% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 1.36% | -4.23% | 23.64% | 76/160 | 1.61% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 1.1% | 223.53% | -57.2% | 108/160 | 0.94% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 2.57% | -64.99% | 53.89% | 100/160 | 4.53% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.67% | 1570% | 17.61% | 103/160 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 1.42% | 610% | 317.65% | 82/160 | 2.52% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 0.34% | -84.04% | -95.37% | 110/160 | 3.74% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 7.34% | 114.62% | 7240% | 54/160 | 3.22% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 0.1% | -95.63% | -50% | 109/160 | 4.24% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.2% | -87.8% | -90.61% | 85/160 | 2.24% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 2.13% | -46.21% | -37.72% | 108/160 | 2.78% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 3.42% | -38.04% | 49.34% | 83/160 | 7.61% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 2.29% | -46.74% | 39.63% | 82/160 | 5.05% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.64% | -63.8% | -58.59% | 65/160 | 2.46% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 3.96% | 1.02% | -28.26% | 97/160 | 7.09% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 5.52% | 137.93% | 28.37% | 63/160 | 7.26% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.3% | 211.59% | -5.08% | 52/160 | 4.65% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 4.53% | 538.03% | 15.56% | 13/160 | 2.55% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 3.92% | 295.96% | 68.97% | 94/160 | 9.66% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.32% | 96.61% | 68.12% | 84/160 | 8.31% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.38% | 187.5% | 94.37% | 89/160 | 5.59% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.71% | 208.7% | -28.28% | 71/160 | 2.1% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 0.99% | 167.81% | -16.1% | 100/160 | 6.33% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 1.18% | 2260% | 145.83% | 74/160 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 0.48% | 173.85% | 108.7% | 80/160 | 3.53% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.23% | 9.52% | 115.75% | 72/160 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | -1.46% | 83.92% | -3020% | 98/160 | 11.35% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 0.05% | 100.95% | 107.69% | 74/160 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | -0.65% | 81.74% | -409.52% | 76/160 | 4.9% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.21% | 116.94% | 102.31% | 66/160 | 2.41% | 华东医药 | 26.63% | 行业排名> |